Currently out of the existing stock ratings of Tim Anderson, 22 are a BUY (31.88%), 37 are a HOLD (53.62%), 10 are a SELL (14.49%).

Tim Anderson

Work Performance Price Targets & Ratings Chart

Analyst Tim Anderson, currently employed at BAML, carries an average stock price target met ratio of 78.58% that have a potential upside of 26.45% achieved within 362 days. Previously, Tim Anderson worked at WOLFE.

Tim Anderson’s has documented 135 price targets and ratings displayed on 13 stocks. The coverage is on Industrials, Healthcare sectors.

Most recent stock forecast was given on JNJ, Johnson & Johnson at 14-Oct-2025.

Wall Street Analyst Tim Anderson

Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for MRNA (MODERNA) at 2/11/2025. The price target of $34 was fulfilled within 7 days with a profit of $3.07 (9.93%) receiving and performance score of 14.18.

Average potential price target upside

of $85.29 (12.04%) on REGN (REGENERON PHARMACEUTICALS).
of $27.93 (22.27%) on LLY (ELI LILLY AND COMPANY).
of $23.69 (42.9%) on MRK (MERCK MPANY).

HUBG Hub Group LLY Eli Lilly and Company MRK Merck mpany PFE Pfizer ABBV AbbVie AMGN Amgen BIIB Biogen BMY Bristol-Myers Squibb Company GILD Gilead Sciences JNJ Johnson & Johnson MRNA Moderna REGN Regeneron Pharmaceuticals AZN AstraZeneca PLC ADR

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Thomas Wadewitz (UBS)